Beyond A Common Infection: Comprehensive Oral Management Strategies For Severe Recurrent Intraoral Herpes
DOI:
https://doi.org/10.30659/medali.8.1.75-79Keywords:
Acyclovir, Herpes Simplex Virus type 1, Multiple Ulcerative, Recurrent Intraoral Herpes, Visual Analog ScaleAbstract
Background: Recurrent intraoral herpes (RIH) is caused by reactivation of Herpes Simplex Virus type 1 (HSV-1). While HSV-1 infection is usually self-limiting, severe cases requiring hospitalization are uncommon and present significant clinical challenges. Delayed diagnosis or inadequate antiviral therapy can contribute to disease progression and increased morbidity.This case study aims to illustrate an effective therapeutic approach for managing severe RIH in a patient presenting with intense pain and difficulty swallowing, emphasizing strategies that enhance patient comfort and improve clinical outcomes.Case: An 24-year-old male presented in a markedly weakened condition with severe difficulty swallowing. Examination revealed multiple ulcerative lesions of varying sizes diffusely throughout the oral cavity, with extensive erythema and severe pain (Visual Analog Scale [VAS] score: 8). Vital signs at presentation were blood pressure 90/60 mmHg and oxygen saturation 91%. Due to his weakened state and significant pain, inpatient care was required for close monitoring and nutritional support.Treatment included systemic acyclovir 400 mg, multivitamins, 0.025% hyaluronic acid mouthwash, 0.9% saline, and petroleum jelly 100%. After seven days of therapy, the patient clinically improved. Lesions gradually decreased in size, number, erythema subsided, and pain significantly reduced, allowing resumption of oral intake. VAS score decreased from 8 at admission to 5 at discharge. Conclusion:Severe RIH can necessitate hospitalization and multidisciplinary management. Early initiation of systemic antiviral therapy combined with supportive care effectively reduces symptoms, improves nutritional intake, and prevents further deterioration. Timely, comprehensive intervention is critical for optimal outcomes in severe HSV-1 reactivation.References
Megawati A, Hidayat W. Lifestyle potential against recurrent intraoral herpes recurrence rate: a case series. Makassar Dent J. 2022;11(1):25–8.
Dwiarie TA, Zakiawati D, Hidayat W. Clinical Response Difference between Acyclovir and Valacyclovir in Recurrent Intraoral Herpes: Adaptation Treatment in Pandemic Situation. e-GiGi. 2022;10(1):149.
Hasanah NT, Hidayat W. Stress as Trigger Factor of HSV-1 Reactivation Causing Recurrent Intraoral Herpes Mimicking HAEM: A Case Report. Int Med Case Rep J. 2022;15(December):699–706.
Sari DK, Rahmayanti F, Sasanti H. Challenges in Diagnosis and Therapy of Recurrent Oral Herpes Infection : Study of Two Cases. 2021;16:73–81.
Alatas H, Wardhany II, Soegyanto AI. TANTANGAN DALAM MANAJEMEN INFEKSI HSV-1 PADA PASIEN GERIATRI : LAPORAN KASUS. :146–54.
Wicaksono I, Hasanah NT, Setiadhi R. Recurrent Intraoral Herpes Simplex Infection Exacerbated by Cytomegalovirus and Toxoplasma With Under-weight Condition : A Case Report. 2024;200–3.
Suniti S, Setiadhi R. Infeksi herpes simpleks virus 1 rekuren dengan faktor predisposisi stres emosional Recurrent herpes simplex virus 1 infection with predisposing factors of emotional stress. J Kedokt Gigi Univ Padjadjaran. 2018;30(3):207.
Jones C. Intimate Relationship Between Stress and Human Alpha ‑ Herpes Virus 1 ( HSV ‑ 1 ) Reactivation from Latency. Curr Clin Microbiol Reports. 2023;1:236–45. Available from: https://doi.org/10.1007/s40588-023-00202-9.
Mahfaza H, Sufiawati I, Satari MH. Prevalensi dan pola penyakit infeksi virus rongga mulut di RSUP Dr. Hasan Sadikin Bandung tahun 2013-2017. Padjadjaran J Dent Res Students. 2019;3(1):50–6.
Gigi MK. Pharmacological and low-level laser therapy in radiation-induced oral mucositis in patients with head and neck cancer. 2025;95(158):95–9.
Malcangi G, Inchingolo AD, Trilli I, Ferrante L, Casamassima L, Nardelli P, et al. Recent Use of Hyaluronic Acid in Dental Medicine. 2025;(Figure 1).
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

This work is licensed under a Creative Commons Attribution 4.0 International License.